Kurosh Parsi (Parsi K)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Topics

Pulmonary Embolism

Magnetic Resonance

General Practice

Top Venues

The Australasian journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Kia Hau Matthew Tan, Fedor Lurie, Hernan Bauza Moreno, Daphne Van den Bussche, Kurosh Parsi, Alun Huw Davies, null null
Management of venous leg ulcers. Phlebology (2024)
Kurosh Parsi, Joseph Grace, David Ewan Connor
Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Phlebology (2024)
Nuo Xu, Manisha Siriwardene, Nikita Naidu, David Ewan Connor, Alun Huw Davies, Peter Gloviczki, Mark H Meissner, Kurosh Parsi
Diagnosis of post-thrombotic syndrome: International union of phlebology (UIP) survey of medical specialists. Phlebology (2024)
Kurosh Parsi, Marianne De Maeseneer, Andre M van Rij, Christopher Rogan, Wendy Bonython, John A Devereux, Christopher K Lekich, Michael Amos, Ahmet Kursat Bozkurt, David Ewan Connor, Alun Huw Davies, Sergio Gianesini, Kathleen Gibson, Peter Gloviczki, Anthony Grabs, Lorena Grillo, Franz Hafner, David Huber, Mark Iafrati, Mark Jackson, Ravul Jindal, Adrian Lim, Fedor Lurie, Lisa Marks, Pauline Raymond-Martimbeau, Peter Paraskevas, Albert-Adrien Ramelet, Rodrigo Rial, Stefania Roberts, Carlos Simkin, Paul K Thibault, Mark Steven Whiteley
Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants. Phlebology (2024)
Joseph Gracé, David Ewan Connor, Kurosh Parsi
Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents. Phlebology (2024)
Kurosh Parsi, David Ewan Connor
Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses. Phlebology (2023)
Kia Hau Matthew Tan, Tomasz Urbanek, Eberhard Rabe, Sergio Gianesini, Kurosh Parsi, Alun Huw Davies, null null
Compression therapy in the management of varicose veins. Phlebology (2023)
Kia Hau Matthew Tan, Mikel Sadek, Lowell Kabnick, Kurosh Parsi, Alun Huw Davies, null null
Management of endothermal heat-induced thrombosis. Phlebology (2023)
Kia Hau Matthew Tan, Fedor Lurie, Dong-Ik Kim, Thomas Wakefield, Kurosh Parsi, Alun Huw Davies
Management of isolated distal deep venous thrombosis. Phlebology (2023)
Kia Hau Matthew Tan, Evgeny Shaydakov, Kurosh Parsi, Alun Huw Davies, null null
Microsclerotherapy. Phlebology 39 (4) (2023)
Kia Hau Matthew Tan, Hernan Bauza Moreno, Beate Bechter-Hugl, Sergio Gianesini, David Connor, Kurosh Parsi, Alun Huw Davies
Sclerotherapy: Indications and safety volumes. Phlebology (2023)
Kia Hau Matthew Tan, Bruce Campbell, Kurosh Parsi, Alun Huw Davies, null null
Management of bleeding varicose veins. Phlebology (2023)
Kia Hau Matthew Tan, Tomasz Urbanek, Eberhard Rabe, Sergio Gianesini, Kurosh Parsi, Alun Huw Davies, null null
Compression therapy in the management of varicose veins. Phlebology 39 (4) (2023)
Kia Hau Matthew Tan, Suresh Vedantham, Sriram Narayanan, Kurosh Parsi, Alun Huw Davies
Interventional treatment for acute iliofemoral deep venous thrombosis. Phlebology (2023)
Kia Hau Matthew Tan, Marc Vuylsteke, John Blebea, Kurosh Parsi, Alun Huw Davies, null null
Management of the patient with the swollen lower limb. Phlebology (2023)
Kia Hau Matthew Tan, Hernan Bauza Moreno, Sarah Thomis, Victor Canata, Sergio Gianesini, Kurosh Parsi, Alun Huw Davies
Truncal ablation: Techniques. Phlebology (2023)
Joseph Gracé, David Ewan Connor, Lourens Bester, Christopher Rogan, Kurosh Parsi
Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents. Phlebology (2023)
Kurosh Parsi, Lois Zhang, Mark Steven Whiteley, Selene Vuong, Kurosh Parsi, Nikita Naidu, Joseph Grace, David Ewan Connor
899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Phlebology (2023)
Mandy Wong, Kurosh Parsi, Kenneth Myers, Marianne De Maeseneer, Joseph A Caprini, Attilio Cavezzi, David Ewan Connor, Alun Huw Davies, Sergio Gianesini, Jean-Luc Gillet, Louis Grondin, Jean-Jérôme Guex, Claudine Hamel-Desnos, Nick Morrison, Giovanni Mosti, Alvaro Orrego, Partsch Hugo, Eberhard Rabe, Pauline Raymond-Martimbeau, Michel Schadeck, Roberto Simkin, Lorenzo Tessari, Paul K Thibault, Jorge H Ulloa, Mark Steven Whiteley, Takashi Yamaki, Steven Zimmet, Kurosh Parsi, Selene Vuong, Anes Yang, Lois Zhang
Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology (2023)
Kia Hau Matthew Tan, Tomasz Urbanek, Eberhard Rabe, Sergio Gianesini, Kurosh Parsi, Alun Huw Davies, null null
Compression therapy in the management of varicose veins. Phlebology 39 (4) (2023)
Kia Hau Matthew Tan, Evgeny Shaydakov, Kurosh Parsi, Alun Huw Davies, null null
Microsclerotherapy. Phlebology 39 (4) (2023)
Kia Hau Matthew Tan, Evgeny Shaydakov, Kurosh Parsi, Alun Huw Davies, null null
Microsclerotherapy. Phlebology (2023)
Kia Hau Matthew Tan, Tomasz Urbanek, Eberhard Rabe, Sergio Gianesini, Kurosh Parsi, Alun Huw Davies, null null
Compression therapy in the management of varicose veins. Phlebology 39 (4) (2023)
Kia Hau Matthew Tan, Evgeny Shaydakov, Kurosh Parsi, Alun Huw Davies, null null
Microsclerotherapy. Phlebology 39 (4) (2023)
Kurosh Parsi, Anes Yang, Patricia Hannaford, David Ewan Connor, Kurosh Parsi
Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms. Phlebology 37 (6) (2022)
Kurosh Parsi, Anes Yang, Patricia Hannaford, David Ewan Connor, Kurosh Parsi
Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies. Phlebology 37 (9) (2022)
Kurosh Parsi, Kurosh Parsi
Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy. The Australasian journal of dermatology 63 (2) (2022)
Kurosh Parsi, David Ewan Connor, Kurosh Parsi
Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes. Phlebology 37 (5) (2022)
Kurosh Parsi, Peter Subramaniam, Alun Huw Davies, Antonios Gasparis, Peter Gloviczki, William A Marston, Mark Meissner, Christopher Rogan, Andre van Rij
Routine use of concurrent fluoroscopic imaging during superficial endovenous interventions: A position statement of the International Union of Phlebology, the Australasian College of Phlebology, the Australia and New Zealand Society for Vascular Surgery, the American Venous Forum, the American Vein and Lymphatic Society, the European College of Phlebology and the Interventional Radiology Society of Australasia. Phlebology (2022)
Kurosh Parsi, Burcu Kim, Alicia A O'Connor, Pooja Kadam, David Ewan Connor
Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses. Phlebology 37 (5) (2022)
Joseph Gracé, David Ewan Connor, Lourens Bester, Christopher Rogan, Kurosh Parsi
LIPIODOL reduces the lytic activity of detergent sclerosants in vitro. Phlebology 36 (10) (2021)
Kaichung Wong, David Ewan Connor, Osvaldo Cooley Andrade, Kurosh Parsi
Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate. Phlebology 36 (7) (2021)
David Ewan Connor, Jessica Gerbelli, An-Ning Chew, Osvaldo Cooley-Andrade, Dulani Goonawardhana, Kelvin Cheung, Kurosh Parsi
Sirolimus and propranolol inhibit endothelial proliferation while detergent sclerosants induce endothelial activation, microparticle release and apoptosis in vitro. Phlebology 35 (8) (2020)